Key Figures

5 Plants

manufacturing sterile forms, cephalosporins, penicillins, dry and liquid forms, soft capsules and inhalation powders.

600 employees

where 50% are managers

30 million

drug boxes are manufactured

71 million de tnd

of turnover

20 % of development

over the last three years

150 million

invested during the last 3 years

1 er manufacture

of cardiovascular drugs and generic antibiotics in Tunisia

ISO 26000

1st Tunisian Pharmaceutical Laboratory adherent to the ISO 26000 standard, related to social responsibility and sustainable development